For the financial year ended 31 December 2015
82
HAW PAR CORPORATION LIMITED
12. INVESTMENT IN SUBSIDIARIES
The Company
2015
2014
$’000
$’000
Equity investments at cost:
Unquoted, at written down cost
421,095
421,095
Allowance for impairment in value
(45,238)
(39,138)
Beginning and end of financial year
375,857
381,957
Details of significant subsidiaries are shown in Note 29.
13. INVESTMENT IN ASSOCIATED COMPANIES
The Company
2015
2014
$’000
$’000
Equity investment at cost
2,895
2,895
(a) Partial disposal of interest in associated company and reclassification to available-for-sale
financial assets
As disclosed in Note 3(a), the Group ceased to have significant influence over the major decisions relating to
the relevant activities of Hua Han Health Industry Holdings Limited (“HHHI”) during the financial year ended 31
December 2015. Consequently, this investment has been reclassified to available-for-sale financial assets (Note 14).
Based on cumulative cash dividends received and net proceeds from the partial disposal of HHHI, the Group has
recovered fully its cash capital cost invested in HHHI.
The Group’s equity accounting/gains on associated companies in the income statement are as follows:
2015
2014
$’000
$’000
Share of profits of associated companies
8,806
11,917
Gain on partial disposal of interest in HHHI
40,540
–
Reclassification of associated company to available-for-sale financial assets
7,030
–
- Transfer of previously recognised translation reserve
4,543
–
- Gain from difference between carrying amount
and fair value on date of loss of significant influence
2,487
–
Equity accounting/gains on associated companies
56,376
11,917
In the opinion of the Directors, the Group’s remaining investment in an associated company (Note 29) as at 31
December 2015 is not material to the Group. There are no contingent liabilities relating to the Group’s interest in
the associated company.
NOT E S TO T H E F I NAN C I A L S TAT EME N T S
(CONTINUED)
